Search research articles
Contact Us
Filters
Showing results (191-200 of 205) with videos related to
Page
of 21
Sort By:
AJNR. American Journal of Neuroradiology
|
March 1, 2000
Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas
R G Henry, D B Vigneron, N J Fischbein, et al.
Journal of Virology
|
January 1, 1996
Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer
T W Dubensky, D A Driver, J M Polo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 1999
Phase II study of phenylacetate in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report
S M Chang, J G Kuhn, H I Robins, et al.
Journal of Virology
|
January 28, 1998
DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector
M J Hariharan, D A Driver, K Townsend, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 13, 2001
Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme
M D Prados, W M Wara, P K Sneed, et al.
Human Gene Therapy
|
August 28, 1998
Genetic immunization of chimpanzees chronically infected with the hepatitis B virus, using a recombinant retroviral vector encoding the hepatitis B virus core antigen
M Sällberg, J Hughes, A Javadian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report
S M Chang, J G Kuhn, J Rizzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group
W K Yung, M D Prados, R Yaya-Tur, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 11, 2021
Prognostic Significance of IDH1/2 Mutation and MGMT Promoter Methylation Status in RTOG 9813
J L Fleming, S Pugh, E H Bell, et al.
The Lancet. Oncology
|
April 9, 2011
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
M J van den Bent, J S Wefel, D Schiff, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 205) with videos related to
Sort By:
Page
of 21
AJNR. American Journal of Neuroradiology
|
March 1, 2000
Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas
R G Henry, D B Vigneron, N J Fischbein, et al.
Journal of Virology
|
January 1, 1996
Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer
T W Dubensky, D A Driver, J M Polo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 1999
Phase II study of phenylacetate in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report
S M Chang, J G Kuhn, H I Robins, et al.
Journal of Virology
|
January 28, 1998
DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector
M J Hariharan, D A Driver, K Townsend, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 13, 2001
Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme
M D Prados, W M Wara, P K Sneed, et al.
Human Gene Therapy
|
August 28, 1998
Genetic immunization of chimpanzees chronically infected with the hepatitis B virus, using a recombinant retroviral vector encoding the hepatitis B virus core antigen
M Sällberg, J Hughes, A Javadian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report
S M Chang, J G Kuhn, J Rizzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group
W K Yung, M D Prados, R Yaya-Tur, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 11, 2021
Prognostic Significance of IDH1/2 Mutation and MGMT Promoter Methylation Status in RTOG 9813
J L Fleming, S Pugh, E H Bell, et al.
The Lancet. Oncology
|
April 9, 2011
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
M J van den Bent, J S Wefel, D Schiff, et al.
Page
of 21